Global Diabetic Neuropathy Market Size, Competitive Analysis, Share, Forecast- 2019-2025

The global diabetic neuropathy market is predicted to grow at a CAGR of over 6% during the forecast period. The factors driving the global diabetic neuropathy market include the rising prevalence of diabetes along with the neurological disorders among the peoples. Diabetic neuropathy is a common disorder for both types of diabetes patients that is type 1 as well as type 2. The main four disorder includes, autonomic neuropathy, affects the heart rate, digestion blood pressure along with other body functions.

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/diabetic-neuropathy-market

The second one is peripheral neuropathy, which affects the nerves of the feet and legs, and causes loss of sensations in legs and hands. The third is proximal neuropathy, which directly affects thighs, legs, buttocks, and hips. Whereas, focal neuropathy affects the wrist, foot, thigh along with pain in the chest, back, and other body parts.

Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/diabetic-neuropathy-market

Rising geriatric population is also one of the key factors encouraging the growth of the global diabetic neuropathy market, as the older peoples are more prone to such diseases. According to WHO, the geriatric population is going to be double in 2050 as compared to 2000. In 2000, the global level proportion of the population over 65 years was 11% which is expected to be 22% by 2050. The geriatric population is expected to reach 2 billion by 2050 as compared to 605 million in 2010. Similarly, the number of geriatric populations over 80 years or older will be almost quadrupled to 395 million from 2000 to 2050.The rise in the geriatric population may also encourage the market during the forecast period.

Growing healthcare expenditures is another motivating factor for the growth of the global diabetic neuropathy industry. For instance, in the economies of Asia-Pacific, the healthcare systems are facing challenges such as the burden of increasing and aging population, delivery of adequate healthcare facilities to the masses, and low per capita income. The healthcare expenditure in these countries is growing significantly with the increasing interest from both the private and public sectors. Economies of the Asia-Pacific region (China and India) are amongst the fastest developing countries in the adoption and implementation of new technologies across the globe.

Further, the key players' contribution to the global diabetic neuropathy market growth is anticipated to be one of the major driving factors of the market. Abbott Laboratories, GlaxoSmithKline Plc, Lupin Ltd., Bioness Inc., and others are some of the key players operating the global diabetic neuropathy market. These key players are indulged in the rapid R&D activities regarding the development of novel and innovative treatment types of diabetic neuropathy during the forecast time frame.

Current Market Trends Covered in the Market Report:

Increased investments by the government along with the private organizations concerning the early diagnosis and treatment of this severe disease is likely to positively affect the diabetic neuropathy market growth during the forecast period
Peripheral neuropathy segment will account for significant growth in the diabetic neuropathy industry
Novel product launches, rapid innovations along with the geographical expansion will be the key growth strategy adopted by the key players to sustain in the market.
Global Diabetic Neuropathy Market – Segmentation

By Treatment Type

Medications
Radiotherapy
Physiotherapy
Others
By Disorder Type

Autonomic Neuropathy
Peripheral Neuropathy
Proximal Neuropathy
Focal Neuropathy
Global Diabetic Neuropathy Market – Segmentation by Region

North America

United States
Canada
Europe

Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific

China
Japan
India
Rest of Asia-Pacific
Rest of the World

Middle East & Africa
Latin America
Company Profiles

Abbott Laboratories, Inc.
Achelios Therapeutics Inc.
Bioness, Inc.
CuronzLtd.
Depomed Inc.
Eli Lilly and Co.
GlaxoSmithKline Plc
Glenmark Pharmaceuticals Ltd.
Innovus Pharmaceuticals, Inc.
Johnson & Johnson
Lupin Ltd.
NeuroMetrix, Inc.
Nevro Corp.
NovaDX
Novartis International AG
Pfizer Inc.
RxFunction, Inc.
Stimwave Technologies Inc.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/diabetic-neuropathy-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.